CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related Genetic Test
At DNA Labs UAE, we offer the CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related Genetic Test for individuals who may be at risk for developing tumors in multiple endocrine glands. This test utilizes NGS (Next-Generation Sequencing) technology to analyze the CDKN2B gene and identify any mutations or variations that may be associated with MEN1.
Test Details
The CDKN2B gene is responsible for regulating cell growth and division. Mutations in this gene can disrupt this process, leading to the development of tumors in the parathyroid glands, pancreas, and pituitary gland. Our NGS genetic testing allows for the simultaneous analysis of multiple genes, including CDKN2B, to accurately diagnose MEN1.
Components and Price
- Test Name: CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Cancer
- Doctor: Oncologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related Genetic Test, it is important for the patient to provide their clinical history. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by MEN1.
Post Test Interpretation
Genetic testing for MEN1 and other inherited conditions should be performed by a qualified healthcare professional, such as a genetic counselor or medical geneticist. These professionals can provide appropriate pre- and post-test counseling and help interpret the results of the NGS genetic testing. It is also important to note that the specific genes included in the test may vary depending on the testing laboratory and the specific panel used.
Conclusion
The CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related Genetic Test offered at DNA Labs UAE is a valuable tool for diagnosing MEN1 and guiding appropriate management and treatment options for individuals and their families. By identifying mutations in the CDKN2B gene, this test allows for early detection and intervention, leading to improved outcomes for patients.
Test Name | CDKN2B Gene Multiple endocrine neoplasia type 1 CDKN2B related Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CDKN2B Gene Multiple endocrine neoplasia type 1, CDKN2B related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDKN2B Gene Multiple endocrine neoplasia type 1, CDKN2B related NGS Genetic DNA Test gene CDKN2B |
Test Details |
The CDKN2B gene is associated with multiple endocrine neoplasia type 1 (MEN1), which is an inherited condition that predisposes individuals to develop tumors in multiple endocrine glands. MEN1 is characterized by the development of tumors in the parathyroid glands, pancreas, and pituitary gland. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the CDKN2B gene. This type of testing can identify mutations or variations in the CDKN2B gene that may be associated with MEN1. The CDKN2B gene is involved in regulating cell growth and division, and mutations in this gene can disrupt this process, leading to the development of tumors. By identifying mutations in the CDKN2B gene, NGS genetic testing can help diagnose MEN1 and guide appropriate management and treatment options for individuals and their families. It is important to note that NGS genetic testing for MEN1 may also include the analysis of other genes associated with the condition, such as the MEN1 gene itself. The specific genes included in the test may vary depending on the testing laboratory and the specific panel used. Genetic testing for MEN1 and other inherited conditions should be performed by a qualified healthcare professional, such as a genetic counselor or medical geneticist, who can provide appropriate pre- and post-test counseling and help interpret the results. |